Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China · Delayed Price · Currency is CNY 31.11
-0.15 (-0.48%)
At close: Feb 13, 2026
SHA:688217 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -27.11 | -15.76 | 7.93 | 40.47 | 47.33 | 38.71 |
Depreciation & Amortization | 43.39 | 43.39 | 44.4 | 35.73 | 37.52 | 28.39 |
Other Amortization | 3.27 | 3.27 | 1.18 | 2.77 | 4.06 | 4.2 |
Loss (Gain) From Sale of Assets | -0.12 | -0.12 | -0.84 | 0.01 | 0.1 | -0.08 |
Asset Writedown & Restructuring Costs | 16.67 | 16.67 | 7.64 | 14.16 | -1.5 | 0.95 |
Loss (Gain) From Sale of Investments | -2.49 | -2.49 | -3.01 | -3.1 | -1.47 | -0.22 |
Provision & Write-off of Bad Debts | 6.65 | 6.65 | 5.03 | 9.56 | 1.06 | 1.01 |
Other Operating Activities | -2.99 | -8.6 | -10.87 | 21.64 | -5.28 | 4.84 |
Change in Accounts Receivable | 14.49 | 14.49 | 182.51 | -101.21 | 2.87 | -20.9 |
Change in Inventory | 9.79 | 9.79 | -15.93 | -16.97 | -10.8 | 8.03 |
Change in Accounts Payable | 2.86 | 2.86 | -167.29 | 64.84 | 3.62 | 6.42 |
Change in Other Net Operating Assets | -4.1 | -4.1 | 2.15 | 8.84 | - | - |
Operating Cash Flow | 54.24 | 59.98 | 45.1 | 73.07 | 77.97 | 70.11 |
Operating Cash Flow Growth | 12.32% | 33.00% | -38.28% | -6.28% | 11.20% | 500.25% |
Capital Expenditures | -50.27 | -39.41 | -109.09 | -106.57 | -95.6 | -52.14 |
Sale of Property, Plant & Equipment | 0.03 | 0.14 | 0.22 | - | 1.39 | 1.69 |
Cash Acquisitions | - | - | - | - | - | 2.43 |
Investment in Securities | -4.25 | -21.98 | 3.56 | 109.03 | -188.56 | -1.47 |
Other Investing Activities | 1.9 | 1.99 | 2.74 | 4.58 | 4.19 | 0.16 |
Investing Cash Flow | -52.6 | -59.27 | -102.58 | 7.04 | -278.57 | -49.33 |
Long-Term Debt Issued | - | - | 20 | 1.35 | - | - |
Total Debt Issued | - | - | 20 | 1.35 | - | - |
Long-Term Debt Repaid | - | -23.08 | -7.22 | -5.87 | -4.62 | -10.9 |
Total Debt Repaid | -38.08 | -23.08 | -7.22 | -5.87 | -4.62 | -10.9 |
Net Debt Issued (Repaid) | -38.08 | -23.08 | 12.78 | -4.52 | -4.62 | -10.9 |
Issuance of Common Stock | - | - | 8.97 | - | 224.04 | - |
Common Dividends Paid | -0.31 | -0.62 | -10.4 | -0.01 | -0.02 | - |
Other Financing Activities | 16.25 | - | - | - | -27.59 | 0.06 |
Financing Cash Flow | -22.14 | -23.7 | 11.36 | -4.53 | 191.8 | -10.84 |
Foreign Exchange Rate Adjustments | 0.73 | 0.66 | 0.84 | 4.69 | -1.54 | -4.67 |
Net Cash Flow | -19.76 | -22.33 | -45.29 | 80.26 | -10.35 | 5.27 |
Free Cash Flow | 3.97 | 20.57 | -64 | -33.5 | -17.63 | 17.97 |
Free Cash Flow Margin | 2.07% | 8.49% | -24.79% | -7.90% | -6.06% | 6.31% |
Free Cash Flow Per Share | 0.07 | 0.36 | -1.13 | -0.60 | -0.35 | 0.43 |
Cash Income Tax Paid | 15.7 | 9.99 | 17.59 | 1.16 | -1.81 | 8.48 |
Levered Free Cash Flow | - | 25.32 | -63.29 | -58.2 | -31.58 | -16.05 |
Unlevered Free Cash Flow | - | 25.87 | -62.77 | -57.86 | -31.28 | -16.01 |
Change in Working Capital | 16.98 | 16.98 | -6.36 | -48.18 | -3.86 | -7.69 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.